ARCHIVES

First Phase 0 Oncology Trial Demonstrates Effectiveness Of New Drug On Its Target

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Decision Network Votes 14-11 for Laetrile Testing

September 29, 1978

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

November 26, 2014

NCAB Calls For Modification Of Rules For NIH Scientist-Industry Collaboration

December 10, 2010

Cancer Groups Criticize FDA For Ignoring Expert Advice.

November 24, 2000

DCT Board Committee Drawing Up Plans On How To Spend Biological Response Modifiers Money

August 31, 1979

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014